MYO News and Press, Myomo Inc. From 04/04/22

Medical robotics firm Myomo (NYSE:MYO) said its Chinese joint venture firm Jiangxi Myomo Medical Assistive Appliance had paid a portion of the technology license fee. The company said it received $1M of the total $2.7M license fee during March, which will be accounted for as revenue duri...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, provides an update on the status of its joint ve...

Gainers: AgriFORCE Growing Systems (NASDAQ:AGRI) +159%. Arcadia Biosciences (NASDAQ:RKDA) +44%. CEA Industries (NASDAQ:CEAD) +32%. Enservco (NYSE:ENSV) +30%. Ebix (NASDAQ:EBIX) +27%. Pop Culture Group (NASDAQ:CPOP) +26%. Natera (NASDAQ:NTRA) +24%. Kala Pharmaceuticals (NASDAQ:KALA) +21%. iPow...

Gainers: Kala Pharmaceuticals (NASDAQ:KALA) +20%. Natera (NASDAQ:NTRA) +17%. Chemomab Therapeutics (NASDAQ:CMMB) +13%. Selecta Biosciences (NASDAQ:SELB) +11%. Longeveron (NASDAQ:LGVN) +7%. Losers: Sunshine Biopharma (NASDAQ:SBFM) -32%. My...

Myomo, Inc. (MYO) Q4 2021 Earnings Conference Call March 9, 2022, 4:30 PM ET Company Participants Paul Gudonis – Chief Executive Officer Dave Henry – Chief Financial Officer Kim Golodetz – LHA Investor Relations Conference Call Participants Scott Henry – Roth Capit...

Myomo press release (NYSE:MYO): Q4 GAAP EPS of -$0.52 misses by $0.03. Revenue of $4.0M (+5.5% Y/Y) beats by $1.01M. For further details see: Myomo GAAP EPS of -$0.52 misses by $0.03, revenue of $4.0M beats by $1.01M

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will participate in tw...

Fourth quarter revenue of $4.0 million up 6% over prior year, full year revenue of $13.9 million up 83% over 2020 Fourth quarter gross margin of 77.4% up 400 basis points over prior year Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NY...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial re...

Brings the total number of patents issued on the MyoPro® device globally to 20 Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fr...